ORC-13661

N/A

Report date: 2025/06/10 10:17:21
NME

Base Information

Drug NameORC-13661
Drug Alias NameORC-13661BPN-13661DB 041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitorsCell death inhibitors
TargetsUpdating
Therapy Area/IndicationsDrug intoxicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of WashingtonOregon Health & Science University
China Registration ClassN/A

Develop Information

Active CompaniesDecibel TherapeuticsOriculaOricula Therapeutics LLC +[4] 
Inactive CompaniesN/A
Active IndicationsDrug intoxicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A